Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag Patients face uncertainty after discovering their source of affordable obesity drugs was unlicensed.

flag Patients who bought affordable obesity drugs from a website are now unsure of their options after discovering the compounding pharmacy lacked the necessary license. flag These patients stockpiled alternative GLP-1 drugs, raising concerns about the legality and safety of their purchases. flag The situation, reported by NPR's Sydney Lupkin, leaves both patients and medical facilities in uncertainty.

12 Articles